An accelerated-phase CML patient with e19a2 junction of BCR/ABL gene -: the first case of transplanted CML with micro bcr

被引：11
|
作者：
Polák, J
Koza, V
Cetkovsky, P
Haskovec, C
机构：
[1] Inst Hematol & Blood Transfus, Dept Mol Genet, CR-12820 Prague 2, Czech Republic
[2] Fac Hosp, Dept Hematooncol, Plzen, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2000年 / 25卷 / 10期
关键词：
D O I：
10.1038/sj.bmt.1702412
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1109 / 1110
页数：2
相关论文
共 50 条
  • [31] First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI
    Saglio, Giuseppe
    Jabbour, Elias
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1523 - 1538
  • [32] E6a2 BCR-ABL fusion with BCR exon 5-deleted transcript in a Philadelphia positive CML responsive to Imatinib
    Popovici, C
    Cailleres, S
    David, M
    Lafage-Pochitaloff, M
    Sainty, D
    Mozziconacci, MJ
    LEUKEMIA & LYMPHOMA, 2005, 46 (09) : 1375 - 1377
  • [33] Transformation of BCR-ABL positive, Philadelphia-negative myelofibrosis to Philadelphia-positive accelerated phase of CML: A case behind the theory.
    Shaklai, M
    Aviram, A
    Blickstein, D
    BLOOD, 2003, 102 (11) : 335B - 335B
  • [34] A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene
    J Polák
    Z Zemanová
    K Michalová
    H Klamová
    J Čermák
    C Haškovec
    Leukemia, 1998, 12 : 250 - 250
  • [35] A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene
    Polák, J
    Zemanová, Z
    Michalová, K
    Klamová, H
    Cermák, J
    Haskovec, C
    LEUKEMIA, 1998, 12 (02) : 250 - 250
  • [36] A CASE OF PH' POSITIVE CHRONIC MYELOID-LEUKEMIA (CML) WITH FEW HEMATOLOGICAL SIGNS AND LOW EXPRESSION OF THE BCR-ABL FUSION GENE INCIPIENT CML - A DISTINCT PHASE OF THE DISEASE
    BIERNAUX, C
    LOOS, M
    SELS, A
    VELU, T
    VERHEST, A
    HUEZ, G
    STRYCKMANS, P
    BLOOD, 1993, 82 (10) : A522 - A522
  • [37] BCR-ABL gene amplification causes reversible cytogentic relapse and resistance to imatinib (STI571) in a chronic phase CML patient
    Gambacorti-Passeri, C
    Bambacorti-Passeri, C
    Bungaro, S
    Cazzanagi, G
    Piazza, R
    Tornaghi, L
    Pogliani, E
    Alberti, D
    Bondi, A
    Varella-Garcia, M
    Corneo, G
    BLOOD, 2002, 100 (11) : 216B - 216B
  • [38] Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia
    Lee, Jaehyeon
    Kim, Dal Sik
    Lee, Hye Soo
    Choi, Sam Im
    Cho, Yong Gon
    ANNALS OF LABORATORY MEDICINE, 2017, 37 (01) : 74 - 76
  • [39] Should young patients with e19a2 type BCR/ABL rearrangement undergo stem cell transplantation?
    Nakamura, F
    Ogawa, S
    Izutsu, K
    Imai, Y
    Maki, K
    Yamagata, T
    Mitani, K
    Hirai, H
    LEUKEMIA & LYMPHOMA, 2003, 44 (02) : 381 - 382
  • [40] Treatment-free remission in e19a2 BCR-ABL1 chronic myeloid leukemia
    Kajiguchi, Tomohiro
    Hashimoto, Ken
    Shimizu, Rie
    Okuno, Shingo
    Takagi, Erina
    ANNALS OF ONCOLOGY, 2021, 32 : S356 - S356
12345